PTK2 and hepatocellular carcinoma: Based on small-molecule FAK inhibitor BI-4464 and CRBN ligand pomalidomide, Popow et al. presented a highly selective PROTAC BI-3663 to hijack UPS for FAK degradation, showing a DC50 of 30 nM in a panel of hepatocellular carcinoma cell lines [246].